AGMB · Agomab Therapeutics NV
$14.28
+0.26 (+1.85%)
At close · Aug 26
Market Cap
$703.26M
Shares
49.25M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
2020932
CUSIP
00860C102
13F (30d)
31 filings
31 filers
Visit website
Investor relations